Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Holds Its Ground Amid Rapid-Fire Changes in D.C.

Angus Worthing, MD, FACP, FACR  |  May 19, 2017

Greetings from your advocacy team in Washington, D.C.!

The tectonic plates of the U.S. political landscape continue to shift. The latest: President Trump fired FBI Director James Comey on Tuesday, May 16; since then, Congress and journalists have had very little bandwidth for much else. But healthcare advocates remember just several news cycles ago when Congress passed a budget that boosted NIH biomedical research funding by $2 billion; the day before that, the House passed the American Health Care Act, or AHCA (and here I thought it was a zombie, neither dead nor alive). Meanwhile, at the executive branch, the last major health administrator is in place after Scott Gottlieb, MD, Commissioner of Food and Drugs, was sworn in Wednesday, May 17, as FDA Commissioner.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Deciphering the AHCA
For those of you who didn’t read the whole healthcare bill (don’t worry, neither did more than a few members of Congress), here is a quick recap of what the AHCA would do if it became law:

  1. Repeal mandates to buy insurance, replaced with a penalty for not maintaining continuous coverage;
  2. Replace the income-based subsidy with age-based tax credits. With age, premiums can rise out of proportion to credits;
  3. Allow states to obtain waivers that remove essential health benefits and preexisting condition protections;
  4. Change Medicaid from direct federal funding to a block-grant system and end Medicaid expansion;
  5. Allocate $115 billion (+8) for high-risk pools; and
  6. Keep the protection for kids to stay on their parents’ plans until age 26.

A few unique things about the bill: First, the House didn’t score the final bill to see what it would cost before voting on it, and second, after it passed, House Republicans celebrated in the White House rose garden. These actions suggest the bill was more of a political maneuver to keep campaign promises than an actual attempt to effect change. And that’s where things get a little messy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Obamacare Chaos
A new poll shows only 21% of Americans support the bill the House passed. Given its unpopularity, it’s not surprising that Senate Democrats are staying away from ACA reform efforts, and Senate Republicans claim to be starting from scratch and working at a Senate pace, not a House pace with healthcare reform. We are hearing that the Senate might write a bill by August.

Meanwhile, on Wednesday, May 17, Aetna announced that it will pull out of exchange plans in 2018. Humana had already pulled out. On Thursday, President Trump threatened to stop the somewhat controversial but highly stabilizing cost-sharing reduction payments from the Treasury to insurers (approximately $7 billion/year). So there is a lot of uncertainty about the state of the Obamacare statutes, as well as the actual marketplace, as we near the June 2017 deadline for insurers to apply to participate in 2018 exchanges.

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:ACR Capitol Hill visitAmerican Health Care Act (AHCA)Angus WorthingHealthcare updateObamacare

Related Articles

    ACR Joins Opposition to Proposed Healthcare Replacement Bill as Written

    March 16, 2017

    The ACR is joining a chorus of voices asking Congress to reconsider several key provisions in the proposed American Health Care Act (AHCA) that it feels could have a detrimental effect on patients. Characterized as a replacement to the Affordable Care Act (ACA), the AHCA eliminates a number of provisions found in the ACA, although…

    The ACR’s Representation in American Medical Association Critical as Review Looms

    March 17, 2017

    There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

    Pointers for Rheumatologists Considering AMA Membership

    February 3, 2012

    Join the AMA. Don’t join because you agree with everything the AMA does. Join so we, as rheumatologists, will continue to have a voice and make a difference.

    Keep ACR at the Table

    March 1, 2007

    Without your help, ACR will lose its clout at the AMA

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences